These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36816621)

  • 21. COVID-19 and liver disease.
    Dufour JF; Marjot T; Becchetti C; Tilg H
    Gut; 2022 Nov; 71(11):2350-2362. PubMed ID: 35701093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of liver injury in risk-stratification and management of patients with COVID-19.
    Shao J; Liang Y; Li Y; Ding R; Zhu M; You W; Wang Z; Huang B; Wu M; Zhang T; Li K; Wu W; Wu L; Wang Q; Xia X; Wang S; Lu L
    Hepatol Int; 2021 Feb; 15(1):202-212. PubMed ID: 33548030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 and multiorgan failure: A narrative review on potential mechanisms.
    Mokhtari T; Hassani F; Ghaffari N; Ebrahimi B; Yarahmadi A; Hassanzadeh G
    J Mol Histol; 2020 Dec; 51(6):613-628. PubMed ID: 33011887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of liver test abnormalities on the prognosis of COVID-19.
    Medetalibeyoglu A; Catma Y; Senkal N; Ormeci A; Cavus B; Kose M; Bayramlar OF; Yildiz G; Akyuz F; Kaymakoglu S; Tukek T
    Ann Hepatol; 2020; 19(6):614-621. PubMed ID: 32920162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature.
    Bucurica S; Ionita Radu F; Bucurica A; Socol C; Prodan I; Tudor I; Sirbu CA; Plesa FC; Jinga M
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver and Biliary Tract Disease in Patients with Coronavirus disease-2019 Infection.
    Ekpanyapong S; Reddy KR
    Gastroenterol Clin North Am; 2023 Mar; 52(1):13-36. PubMed ID: 36813421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver injury in the era of COVID-19.
    Cichoż-Lach H; Michalak A
    World J Gastroenterol; 2021 Feb; 27(5):377-390. PubMed ID: 33584070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiological mechanisms of liver injury in COVID-19.
    Nardo AD; Schneeweiss-Gleixner M; Bakail M; Dixon ED; Lax SF; Trauner M
    Liver Int; 2021 Jan; 41(1):20-32. PubMed ID: 33190346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 vaccination and liver disease.
    Ozaka S; Kobayashi T; Mizukami K; Murakami K
    World J Gastroenterol; 2022 Dec; 28(48):6791-6810. PubMed ID: 36632314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor outcomes in patients with cirrhosis and Corona Virus Disease-19.
    Shalimar ; Elhence A; Vaishnav M; Kumar R; Pathak P; Soni KD; Aggarwal R; Soneja M; Jorwal P; Kumar A; Khanna P; Singh AK; Biswas A; Nischal N; Dar L; Choudhary A; Rangarajan K; Mohan A; Acharya P; Nayak B; Gunjan D; Saraya A; Mahapatra S; Makharia G; Trikha A; Garg P
    Indian J Gastroenterol; 2020 Jun; 39(3):285-291. PubMed ID: 32803716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of COVID-19 on patients with compensated chronic liver diseases.
    Ji D; Zhang D; Yang T; Mu J; Zhao P; Xu J; Li C; Cheng G; Wang Y; Chen Z; Qin E; Lau G
    Hepatol Int; 2020 Sep; 14(5):701-710. PubMed ID: 32734407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 and comorbidities of hepatic diseases in a global perspective.
    Ahmad A; Ishtiaq SM; Khan JA; Aslam R; Ali S; Arshad MI
    World J Gastroenterol; 2021 Apr; 27(13):1296-1310. PubMed ID: 33833483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Features and Liver Injury in Patients with COVID-19 in the Japanese Population.
    Abe K; Yamamoto T; Matsumoto K; Kikuchi K; Miura R; Tachizawa N; Asaoka Y; Takezawa T; Matsunaga N; Obi S; Tanaka A
    Intern Med; 2020; 59(19):2353-2358. PubMed ID: 32999264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.
    Ge J; Pletcher MJ; Lai JC;
    Gastroenterology; 2021 Nov; 161(5):1487-1501.e5. PubMed ID: 34284037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of COVID-19 patients with chronic liver diseases and liver transplants.
    Hu X; Sun L; Guo Z; Wu C; Yu X; Li J
    Ann Hepatol; 2022; 27(1):100653. PubMed ID: 34929350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Danish population-based case series of patients with liver cirrhosis and coronavirus disease 2019.
    Attauabi M; Burisch J; Bendtsen F; Kimer N
    Scand J Gastroenterol; 2021 Apr; 56(4):453-457. PubMed ID: 33590789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection.
    Zou X; Fang M; Li S; Wu L; Gao B; Gao H; Ran X; Bian Y; Li R; ShanshanYu ; Ling J; Li D; Tian D; Huang J
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):597-603. PubMed ID: 32553907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review.
    Cha MH; Regueiro M; Sandhu DS
    World J Gastroenterol; 2020 May; 26(19):2323-2332. PubMed ID: 32476796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation analysis of coagulation dysfunction and liver damage in patients with novel coronavirus pneumonia: a single-center, retrospective, observational study.
    Chen S; Liu H; Li T; Huang R; Gui R; Zhang J
    Ups J Med Sci; 2020 Nov; 125(4):293-296. PubMed ID: 32990149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.